Advance Medical Technologies and Therapeutics

India’s medical technology ecosystem is undergoing a major transformation, evolving from an import-dependent consumer market into a self-sustaining global innovation hub.

Government of India initiatives, including the Ayushman Bharat Digital Mission, Biopharma SHAKTI initiative and Medical Devices Parks Scheme, aim to strengthen domestic manufacturing and reduce dependence on imports.

Building on these initiatives, TDB is launching the call for proposal “Advance Medical Technologies and Therapeutics” to strengthen India's biomedical ecosystem and support the development, manufacturing and commercialization of advanced medical technologies and therapeutics.

The present call for proposal aims to:

• Identify areas requiring strategic interventions and develop socially relevant technologies that improve access to affordable, quality medical and healthcare devices.
• Encourage the production of competitive products and reduce import dependence by supporting the manufacturing and commercialization of medium- to high-technology medical devices.
• Invest in core technological strengths to enhance the competitiveness of Indian industry and increase India's share of high-end, complex medical devices in the global market.

Technology Development Board invites proposals from Indian industrial concerns operating in the medical technologies and therapeutics sector. Funding support is intended for new technology and product development, manufacturing and commercialization, as well as technology adaptation for new product development and commercialization.

Considering India's socioeconomic priorities, applicants are encouraged to apply in the following focus areas, which are not exhaustive:

1. Clinical Diagnostics: Radiology products involving ionizing and non-ionizing radiation; nuclear imaging devices; anesthetic and cardio-respiratory medical devices, including catheters; renal care devices; cancer care devices; and artificial intelligence-based medical devices.
2. Localized Surgical Robotics and Smart Implants: Implants, including prosthetic limbs and organs; implantable hearing aids and ear prostheses; ophthalmic prosthetics, including artificial eyeballs, corneas and eye socket replacements; voice prostheses; and related technologies.
3. Regenerative Therapy Devices: Devices related to cell therapies, immunomodulation therapies and tissue engineering, including laboratory-grown organs and tissues.
4. Advanced Biologics: Cell and gene therapies, CAR-T cell innovation, regenerative medicines, next-generation biologics and antibody-drug conjugates, targeted oncology, immuno-oncology pipelines, indigenous small molecules for chronic diseases and other biotherapeutics.

• Any company incorporated under the Companies Act, 1956 or the Companies Act, 2013.
• The company must intend to commercialize the technology.

TDB offers the following modes of funding:

• Loan at 5% simple annual interest.
• Equity.

Following approval of the proposal, TDB will invite applications from eligible Indian companies operating in the above-mentioned domains and other related areas.

Interested companies will be required to submit their applications through the online proposal submission portal of TDB.

The call will remain open for one month from the date of approval.

Visit the TDB Official Website 

Official Website

Technology Development Board (TDB) 

Dr. Richa Panwar

Sr. Project Coordinator

Technology Development Board (TDB)

Email: richa.panwar@tdb.gov.in 

Phone: +91 7417941878 

Website: https://tdb.gov.in/ 

Important Dates:

Proposed Start Date of Call Launch: 23rd October 2026

Proposed End Date: 23rd November 2026